Profile
Sherree E.
Frazier worked as a Senior Director at CytoCore, Inc., a Health Manager at Cytyc Prenatal Products Corp., and as Head-North American Clinical Sales at Qiagen, Inc. She also served as Vice President-Sales & Marketing at Sera Prognostics, Inc. from 2012 to 2017.
Frazier holds an MBA from Central Michigan University and an undergraduate degree from the University of Florida.
Former positions of Sherree E. Frazier
| Companies | Position | End |
|---|---|---|
| SERA PROGNOSTICS, INC. | Corporate Officer/Principal | 28/02/2017 |
Cytyc Prenatal Products Corp.
 Cytyc Prenatal Products Corp. Medical SpecialtiesHealth Technology Cytyc Prenatal Products Corp. provides products for the diagnosis of pregnancy related and female reproductive disorders. The company also designs, develops, and manufactures women health care products. It was founded in 1985 and is headquartered in Sunnyvale, CA | Corporate Officer/Principal | - |
Qiagen, Inc.
 Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Sales & Marketing | - |
CytoCore, Inc.
 CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Director/Board Member | - |
Training of Sherree E. Frazier
| University of Florida | Undergraduate Degree |
| Central Michigan University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SERA PROGNOSTICS, INC. | Health Services |
| Private companies | 3 |
|---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
Qiagen, Inc.
Qiagen, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen, Inc. provided technologies for separating, purifying and handling nucleic acids. The company was founded in 1988 and was headquartered in Germantown, MD. | Commercial Services |
Cytyc Prenatal Products Corp.
Cytyc Prenatal Products Corp. Medical SpecialtiesHealth Technology Cytyc Prenatal Products Corp. provides products for the diagnosis of pregnancy related and female reproductive disorders. The company also designs, develops, and manufactures women health care products. It was founded in 1985 and is headquartered in Sunnyvale, CA | Health Technology |
- Stock Market
- Insiders
- Sherree E. Frazier
